0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Green Electrospun Poly(vinyl alcohol)/Gelatin-Based Nanofibrous Membrane by Incorporating 45S5 Bioglass Nanoparticles and Urea for Wound Dressing Applications: Characterization and In Vitro and In Vivo Evaluations

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study reports the fabrication and characterization of poly(vinyl alcohol) (PVA) and gelatin (Gel)-based nanofiber membranes cross-linked with citric acid (CA) by a green electrospinning method in which nano 45S5 bioglass (BG) and urea were incorporated. Various combinations of PVA, gelatin, and BG were prepared, and nanofiber membranes with average fiber diameters between 238 and 595 nm were fabricated. Morphological, chemical, and mechanical properties, porosity, swelling, water retention, and water vapor transmission rate of the fabricated membranes were evaluated. PVA:Gel (90:10), 15% CA, and 3% BG were determined as the optimum blend for nanofiber membrane fabrication via electrospinning. The membrane obtained using this blend was further functionalized with 10% w/w polymer urea coating by the electrospray method following the cross-linking. In vitro biocompatibility tests revealed that the fabricated membranes were all biocompatible except for the one that functionalized with urea. In vivo macroscopic and histopathological analysis results of PVA/Gel/BG and PVA/Gel/BG/Urea treated wounds indicated increased collagenization and vascularization and had an anti-inflammatory effect. Furthermore, careful examination of the in vivo macroscopic results of the PVA/Gel/BG/Urea membrane indicated its potential to decrease uneven scar formation. In conclusion, developed PVA/Gel/BG and PVA/Gel/BG/Urea electrospun membranes with multifunctional and biomimetic features may have the potential to be used as beneficial wound dressings.

          Related collections

          Most cited references91

          • Record: found
          • Abstract: found
          • Article: not found

          Chronic Wound Healing: A Review of Current Management and Treatments

          Wound healing is a complex, highly regulated process that is critical in maintaining the barrier function of skin. With numerous disease processes, the cascade of events involved in wound healing can be affected, resulting in chronic, non-healing wounds that subject the patient to significant discomfort and distress while draining the medical system of an enormous amount of resources. The healing of a superficial wound requires many factors to work in concert, and wound dressings and treatments have evolved considerably to address possible barriers to wound healing, ranging from infection to hypoxia. Even optimally, wound tissue never reaches its pre-injured strength and multiple aberrant healing states can result in chronic non-healing wounds. This article will review wound healing physiology and discuss current approaches for treating a wound.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Human skin wounds: a major and snowballing threat to public health and the economy.

            ABSTRACT In the United States, chronic wounds affect 6.5 million patients. An estimated excess of US$25 billion is spent annually on treatment of chronic wounds and the burden is rapidly growing due to increasing health care costs, an aging population and a sharp rise in the incidence of diabetes and obesity worldwide. The annual wound care products market is projected to reach $15.3 billion by 2010. Chronic wounds are rarely seen in individuals who are otherwise healthy. In fact, chronic wound patients frequently suffer from "highly branded" diseases such as diabetes and obesity. This seems to have overshadowed the significance of wounds per se as a major health problem. For example, NIH's Research Portfolio Online Reporting Tool (RePORT; http://report.nih.gov/), directed at providing access to estimates of funding for various disease conditions does list several rare diseases but does not list wounds. Forty million inpatient surgical procedures were performed in the United States in 2000, followed closely by 31.5 million outpatient surgeries. The need for post-surgical wound care is sharply on the rise. Emergency wound care in an acute setting has major significance not only in a war setting but also in homeland preparedness against natural disasters as well as against terrorism attacks. An additional burden of wound healing is the problem of skin scarring, a $12 billion annual market. The immense economic and social impact of wounds in our society calls for allocation of a higher level of attention and resources to understand biological mechanisms underlying cutaneous wound complications.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Transition from inflammation to proliferation: a critical step during wound healing

              The ability to rapidly restore the integrity of a broken skin barrier is critical and is the ultimate goal of therapies for hard-to-heal-ulcers. Unfortunately effective treatments to enhance healing and reduce scarring are still lacking. A deeper understanding of the physiology of normal repair and of the pathology of delayed healing is a prerequisite for the development of more effective therapeutic interventions. Transition from the inflammatory to the proliferative phase is a key step during healing and accumulating evidence associates a compromised transition with wound healing disorders. Thus, targeting factors that impact this phase transition may offer a rationale for therapeutic development. This review summarizes mechanisms regulating the inflammation–proliferation transition at cellular and molecular levels. We propose that identification of such mechanisms will reveal promising targets for development of more effective therapies.
                Bookmark

                Author and article information

                Journal
                ACS Omega
                ACS Omega
                ao
                acsodf
                ACS Omega
                American Chemical Society
                2470-1343
                02 May 2024
                14 May 2024
                : 9
                : 19
                : 21187-21203
                Affiliations
                []Faculty of Chemical and Metallurgical Engineering, Department of Bioengineering, Yildiz Technical University , 34220 İstanbul, Türkiye
                []Faculty of Rafet Kayis Engineering, Genetic and Bioengineering Department, Alanya Alaaddin Keykubat University , 07425 Antalya, Türkiye
                [§ ]Nutrition and Food Technology Department, Jordan University of Science and Technology , Irbid 3030, Jordan
                []Faculty of Veterinary, Department of Clinical Sciences, Hatay Mustafa Kemal University , 31060 Hatay, Türkiye
                []Faculty of Medicine, Department of Pathology, Hatay Mustafa Kemal University , 31060 Hatay, Türkiye
                [# ]Faculty of Veterinary, Department of Biostatistics, Hatay Mustafa Kemal University , 31060 Hatay, Türkiye
                Author notes
                [* ]Email: t.mervesoylu@ 123456gmail.com . Tel.: +90 0(531) 932 18 93.
                Author information
                https://orcid.org/0009-0006-5374-9316
                Article
                10.1021/acsomega.4c01102
                11097359
                6dd751db-c0ca-4afa-abc4-f60c1a5803a1
                © 2024 The Authors. Published by American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 03 February 2024
                : 14 February 2024
                : 13 February 2024
                Funding
                Funded by: Türkiye Bilimsel ve Teknolojik Arastirma Kurumu, doi 10.13039/501100004410;
                Award ID: BIDEB/2211-A
                Funded by: Yüksekögretim Kurulu, doi 10.13039/501100007246;
                Award ID: 100/2000
                Funded by: Yildiz Teknik Ãœniversitesi, doi 10.13039/501100006560;
                Award ID: FBA-2021-4219
                Categories
                Article
                Custom metadata
                ao4c01102
                ao4c01102

                Comments

                Comment on this article